Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adicet Bio Inc
(NQ:
ACET
)
1.490
-0.040 (-2.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Adicet Bio Inc
< Previous
1
2
3
4
Next >
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 30, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 27, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
August 19, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 13, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in Upcoming Investor Conferences
August 01, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
July 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
June 24, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
June 05, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
May 29, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
May 07, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
April 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
March 19, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 11, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
February 29, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
January 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
January 25, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio, Inc. Announces Pricing of Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio, Inc. Announces Proposed Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
January 04, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
January 03, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit